Modern Pathology

Elsevier BV

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Modern Pathology is a journal published by Elsevier BV in United States. It is listed in MEDLINE according to the sources read. Declared publication charge: 4,790 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier BV
ISSN
0893-3952 · 1530-0285
Country
United States
Access
Not open access / not declared
Declared publication charge
4,790 USD
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 1988-01-01
Indexing
MEDLINE
APC
4,790 USD
Declared review time (DOAJ)
—
Actual review time (measured)
112 days received→accepted — computed from PubMed (n=98)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

6269

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

212

i10-index

4455

From OpenAlex open data (CC0).

Editorial & policy4
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Norwegian register (HK-dir)— 2027
Level 2 — top tier (~20% of the field's channels)
Open references deposited at Crossref
97%
ORCID iDs in current deposits
95%
Deposits licence metadata at Crossref
✓
Identity & continuity3
Source type
journal
NLM unique ID (PubMed)
8806605
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Sarcoma Diagnosis and Treatment
  • Sarcoma Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Genetic factors in colorectal cancer
  • Genetic factors in colorectal cancer
Show all subjects (50)
  • Breast Lesions and Carcinomas
  • Breast Lesions and Carcinomas
  • Breast Cancer Treatment Studies
  • Breast Cancer Treatment Studies
  • Ovarian cancer diagnosis and treatment
  • Ovarian cancer diagnosis and treatment
  • Viral-associated cancers and disorders
  • Viral-associated cancers and disorders
  • HER2/EGFR in Cancer Research
  • HER2/EGFR in Cancer Research
  • Pancreatic and Hepatic Oncology Research
  • Pancreatic and Hepatic Oncology Research
  • Cancer and Skin Lesions
  • Neuroendocrine Tumor Research Advances
  • Cancer and Skin Lesions
  • Neuroendocrine Tumor Research Advances
  • Lung Cancer Treatments and Mutations
  • Endometrial and Cervical Cancer Treatments
  • Lung Cancer Treatments and Mutations
  • Endometrial and Cervical Cancer Treatments
  • Renal and related cancers
  • Cutaneous Melanoma Detection and Management
  • Renal and related cancers
  • Cutaneous Melanoma Detection and Management
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
  • Cervical Cancer and HPV Research
  • Cervical Cancer and HPV Research
  • Renal cell carcinoma treatment
  • Cancer-related Molecular Pathways
  • Salivary Gland Tumors Diagnosis and Treatment
  • Salivary Gland Tumors Diagnosis and Treatment
  • AI in cancer detection
  • AI in cancer detection
  • Cancer-related Molecular Pathways
  • Renal cell carcinoma treatment
  • Prostate Cancer Treatment and Research
  • Soft tissue tumor case studies
  • Soft tissue tumor case studies
  • Radiomics and Machine Learning in Medical Imaging
  • Radiomics and Machine Learning in Medical Imaging
  • Prostate Cancer Treatment and Research

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: